Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-21-Speech-2-554"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20100921.19.2-554"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
"Mr President, allow me to start by underlining once again how much the Commission appreciates the commitment and interest of the Members of this House on this dossier.
Although this is a highly complex proposal, it contains several important and sensitive aspects from a political point of view. The remarks you have just made and the questions you have raised illustrate just how well the Members of this House have understood the various facets of this issue.
I must also reiterate the Commission’s concerns in terms of the amendments to the scope of the EU authorisation system. Although the Commission can, in principle, support extending the EU authorisation system to a larger group of biocidal products, we consider that this should be accompanied by sufficient resources for the European Chemicals Agency (ECHA) and the Commission, and gradual implementation mechanisms. It is only if these two conditions are met that we shall be able to implement an efficient system, which is our common objective.
As regards the questions raised by Mrs Sartori and Mr Leinen as to how to guarantee that the ECHA will be able to take on this workload in future, ensuring that the resources made available to the ECHA are adequate is one of the Commission’s main concerns in connection with proposals to extend the scope of the EU authorisation system.
We are working with the sector in order to establish more precisely the number of biocidal products currently available on the EU market. Estimates vary from 9 000 to 60 000 products. It is therefore very difficult to forecast the additional workload that including a larger number of products in the centralised system would involve for the ECHA. The general objective of the proposal for a regulation is to improve the functioning of the internal market in biocidal products, while at the same time guaranteeing a high level of protection for the environment and public health.
I am even going to reply to Mr Schnellhardt on nanomaterials. The Commission agrees that we need a definition of nanomaterials. It is waiting for the outcome of the public enquiry organised by one of our scientific committees and hopes to be able to propose a definition which meets the criteria in the near future.
As far as Amendment 243 is concerned, I shall reply to Mr Davies. The Commission cannot support this amendment, because it calls into question Annex I, which is based on an in-depth impact study and which has just entered into force.
I am therefore satisfied that we have done a good job. We must continue the constructive dialogue between Parliament, the Council and the Commission at second reading."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples